Author:
Snidvongs Kornkiat,Thanaviratananich Sanguansak
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference90 articles.
1. •• Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology Suppl. 2012;50(23):1–298. The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of evidence based position papers with regard to rhinosinusitis and nasal polyps. Management schemes based on the evidence are analyzed, summarized and proposed.
2. Harvey RJ, Schlosser RJ. Local drug delivery. Otolaryngol Clin N am. 2009;42(5):829–45. ix
3. • Lam M, Hull L, Imrie A, Snidvongs K, Chin D, Pratt E, et al. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis. Am J Rhinol Allergy. 2015;29(3):175–81. Assessing sinus mucosal samples from 39 patients undergoing sinus surgery, this group demonstrated that epithelial-derived cytokines including IL-25 and IL-33 implicated in the initiation of T-helper 2 inflammation and eosinophilia in chronic rhinosinusitis. IL-25 and IL-33 overexpression was observed in eosinophilic inflammation.
4. Lee SH. Mechanisms of glucocorticoid action in chronic rhinosinusitis. Allergy Asthma Immunol Res. 2015;7(6):534–7.
5. Mullol J, Obando A, Pujols L, Alobid I. Corticosteroids treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin N am. 2009;29(4):657–68.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献